Howard Hughes Medical Institute’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8
Closed -$909 169
2025
Q4
$909 Hold
8
﹤0.01% 498
2025
Q3
$1.06K Sell
8
-1
-11% -$137 ﹤0.01% 498
2025
Q2
$1.28K Buy
+9
New +$1.27K ﹤0.01% 495
2017
Q3
Sell
-653
Closed -$42K 60
2017
Q2
$42K Buy
+653
New +$43.2K 0.01% 153
2016
Q4
Sell
-6,666
Closed -$440K 154
2016
Q3
$440K Buy
6,666
+4,026
+153% +$283K 0.11% 97
2016
Q2
$204K Buy
+2,640
New +$200K 0.07% 113
2016
Q1
Sell
-3,645
Closed -$254K 174
2015
Q4
$254K Sell
3,645
-3,199
-47% -$234K 0.04% 125
2015
Q3
$495K Sell
6,844
-2,463
-26% -$191K 0.09% 96
2015
Q2
$740K Buy
9,307
+1,979
+27% +$163K 0.16% 84
2015
Q1
$596K Buy
7,328
+3,304
+82% +$254K 0.08% 91
2014
Q4
$305K Buy
4,024
+1,376
+52% +$104K 0.08% 117
2014
Q3
$194K Buy
2,648
+1,943
+276% +$142K 0.04% 119
2014
Q2
$51K Sell
705
-2,634
-79% -$183K 0.01% 142
2014
Q1
$230K Buy
3,339
+1,027
+44% +$68.2K 0.03% 76
2013
Q4
$147K Buy
+2,312
New +$136K 0.02% 109
2013
Q3
Sell
-1,390
Closed -$84K 208
2013
Q2
$84K Buy
+1,390
New +$86.8K 0.03% 142

Other funds holding DVA

Howard Hughes Medical Institute's DVA Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of DaVita (DVA) in Q1 2026, closing a stake of 8 shares — an estimated $909 sold.

Howard Hughes Medical Institute first reported a position in DVA in Q2 2013 and held it in 16 quarters. The position peaked at $740K in Q2 2015. 583 funds tracked by Wall St. Rank hold DVA as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining DaVita position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 8 DaVita shares in Q1 2026, an estimated $909.
  • Howard Hughes Medical Institute first reported a position in DaVita in Q2 2013 and held it in 16 quarters.
  • Howard Hughes Medical Institute's DaVita position peaked at $740K in Q2 2015.
  • 583 funds tracked by Wall St. Rank held DaVita as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.